PGLa

Research use only, not for human use.

PGLa is a cationic antimicrobial peptide (AMP) originally isolated from frog. It has been shown to have antibacterial,antifungal,and antiviral,activities.

PGLa is a cationic antimicrobial peptide (AMP) originally isolated from frog. It has been shown to have antibacterial,antifungal,and antiviral,activities. (In Vitro):PGLa is a peptide starting with a glycine and ending with a leucine amide. PGLa is bacteriostatic against both Gram-positive and Gram-negative bacteria with MIC values of 64 and 32 mg/L against S. aureus and E. coli, respectively.

PGLa is a peptide starting with a glycine and ending with a leucine amide. GLa is bacteriostatic against both Gram-positive and Gram-negative bacteria with MIC values of 64 and 32 mg/L against S. aureus and E. coli, respectively.

——

——

GPCR/G Protein

Antibacterial

Anti-bacteria

——

——

102068-15-5

1968.45

C88H162N26O22S

>98% (HPLC)

——

——

Sequence:Gly-Met-Ala-Ser-Lys-Ala-Gly-Ala-Ile-Ala-Gly-Lys-Ile-Ala-Lys-Val-Ala-Leu-Lys-Ala-Leu-NH2

(-20℃)

With Ice Pack

≥ 2 years